SEC Form 4 · accession 0001883914-26-000003
Enveric Biosciences, Inc. · ENVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph Edward Tucker
Officer — Chief Executive Officer · Director
Period of report
Jun 1, 2026
Accepted (ET)
Jun 3, 2026 · 4:32 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000890821
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 1, 2026 | A | 201,124 | $0.00 | A | 271,479 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the restricted stock units (the "RSUs") granted to the reporting person pursuant to the Enveric Biosciences, Inc. (the "Company") 2020 Long-Term Incentive Plan, as amended. For each vested restricted stock unit, the reporting person will be entitled to receive one share of common stock. One-fourth of the RSUs will vest upon the one-year anniversary of the date of issuance. An additional one-thirty-sixth of the RSUs will vest each month following the first vesting date. Any remaining RSUs will vest on the fourth anniversary of the date of issuance. Vesting is conditioned upon continued employment by the Company.